sanofi.com
What changed on the page
Added coverage of “Dual-targeting library designing novel bispecific therapeutics” and “Advancing the Next Generation of Immune-Mediated Disease Treatments.”
sanofi.comRead the full source
SanofiMarketing shift
Sanofi increased emphasis on its rare-disease and translational research pipeline, including bispecific therapeutics and dual-targeting strategies.
Source
Extracted by Autobound
From the Signal API record- Signal
- Marketing shift
What this signalsWebsite changes often show new positioning, products or customers.
- Page
- /
More from Sanofi
- PatentsSanofi Biotechnology was granted a patent for rheumatoid arthritis treatment compositions.Patents
- InvestmentSanofi opens new $925M manufacturing facility in TorontoInvestment
- RedditA commenter criticizes Sanofi for using an outdated CTMS called IMPACT, having disorganized study managers, and being one of the worst sponsors they've worked with.Reddit
- In developmentSanofi opens $925-million flu vaccine facility in TorontoIn development
- New locationNearly $1-billion vaccine manufacturing plant just opened in TorontoNew location
- Headcount growthSanofi inaugurates new flu vaccine facility, Canada's largest biomanufacturing investmentHeadcount growth
Latest signals at other companies
- Website changes1X1X expanded hiring for manufacturing and supply-chain functions, including robotics assembly, material handling, ERP systems, and global trade compliance.Website changes
- Website changesAddeparAddepar highlighted a global customer footprint of more than 9 trillion assets across 1,400+ clients and 60+ countries.Website changes
- Federal contractsAES$335K federal contract from Department of Homeland SecurityFederal contracts
The full record
From the Signal API recordDetails
- Why it matters
- The messaging reinforces Sanofi’s differentiation in rare diseases and supports future translational development and commercialization.
Extraction
- Relevance
- 62%
- Detected
- Aug 17, 2026
- signal_type
website-intelligence- signal_subtype
marketingShift
Use this data
Get every website changes signal for Sanofi and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Sanofi this week?”
Send it to your own tools
The Signal API returns website changes signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full website-intelligence record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/0194028b-c9c0-5e0a-81c8-49e5869cf9b5 returns this record as JSON. POST /v1/companies/enrich returns every signal for sanofi.com.
{
"signal_id": "0194028b-c9c0-5e0a-81c8-49e5869cf9b5",
"signal_type": "website-intelligence",
"signal_subtype": "marketingShift",
"detected_at": "2026-08-17T00:00:00+00:00",
"company": {
"name": "Sanofi",
"domain": "sanofi.com"
},
"data": {
"summary": "Sanofi increased emphasis on its rare-disease and translational research pipeline, including bispecific therapeutics and dual-targeting strategies.",
"evidence": "Added coverage of “Dual-targeting library designing novel bispecific therapeutics” and “Advancing the Next Generation of Immune-Mediated Disease Treatments.”",
"relevance": 0.62,
"source_url": "https://www.sanofi.com/",
"impact_rationale": "The messaging reinforces Sanofi’s differentiation in rare diseases and supports future translational development and commercialization."
}
}
curl https://signals.autobound.ai/v1/signals/0194028b-c9c0-5e0a-81c8-49e5869cf9b5 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"sanofi.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.